+1-337-202-5200
support@erdheim-chester.org
Join Us
Donate
English
English
French Spanish German Italian Portuguese Hebrew Hindi Greek Chinese Dutch Norwegian
ECD Global Alliance Logo
English
English
French Spanish German Italian Portuguese Hebrew Hindi Greek Chinese Dutch Norwegian
  • What is ECD
        • Overview
        • Care Centers
        • Diagnosis
        • Care Monitoring
        • Treatments
        • Symptoms
  • Patients/Loved Ones
        • Care Centers
        • Webinars
        • Testimonials
        • What Should I Do
        • Community Chats
        • Treatment Trials
        • Family / Carer General Information
        • Connect
        • Patient & Family Gatherings
        • Patient Surveys / Studies
        • Family / Carer Resources
        • Self-Care with ECD
        • Patient Resources
        • Request More Information
        • Family Members
        • Caregiver Connect
  • Medical Professionals
        • Care Centers
        • Treatment Trials
        • General Information
        • Patient Surveys / Studies
        • Grant Opportunities
        • Payer Appeals
        • Medical Resources
        • Annual Medical Symposiums
  • About Us
        • Our Story
        • Board and Staff
        • Resources
        • Medical Advisory Board
        • Member Locations
        • News
        • Patient Stories
        • Events
        • History
  • How to Help
        • Spread the Word
        • Award Nominations
        • Host Fundraisers
        • Ways to Donate
        • Volunteer
  • Join Us
  • Donate
  • Join Us
  • Donate
The ECD Global Alliance Welcomes Israel ECD Referral Care Center

The ECD Global Alliance Welcomes Israel ECD Referral Care Center

Dec 31, 2017

Assuta Medical Center joins an elite group of hospitals skilled in treating Erdheim-Chester disease patients.
Care Network Serves Australian Rare Disease Patients

Care Network Serves Australian Rare Disease Patients

Dec 31, 2017

The Erdheim-Chester Disease Global Alliance is proud to announce the first ECD Referral Care Center to be located in Australia.
FDA Approves Zelboraf (Vemurafenib) for Erdheim-Chester Disease with BRAF V600 Mutation

FDA Approves Zelboraf (Vemurafenib) for Erdheim-Chester Disease with BRAF V600 Mutation

Dec 31, 2017

First FDA-Approved drug for this rare disease

December 9, 2017

Feb 10, 2017

November 18, 2017

Feb 10, 2017

« Older Entries
Next Entries »

Search Our Blogs

Recent Posts

  • Introducing Mary Burgin Executive Director Erdheim-Chester Disease Global Alliance
  • Research Matters
  • Save the Date: 2027 ECDGA Medical Symposium in Glasgow
  • Save the Date: 2027 ECDGA Patient and Family Gathering
  • Research Funding Opportunity
ECD Global Alliance Logo

Dedicated to the awareness, support, education, and research related to Erdheim-Chester Disease since 2008.

Quick Links

What is ECD

Care Centers

Patient Resources

Research

Get Involved

Join Us

Donate

Community Chats

Events

Contact

+1-337-202-5200

Email Us

P.O. Box 775
DeRidder, LA 70634 USA

Platinum Transparency 2025
Charity Navigator
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Rare Connect
Designed by Ask the Egghead, Inc. © 2026 ECD Global Alliance. All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

Designed by Ask the Egghead, Inc. © 2026 ECD Global Alliance. All rights reserved.

h

Join Us



Donate



Care Centers



Events

h

Join Us



Donate



Care Centers



Events

We've detected you might be speaking a different language. Do you want to change to:
English
English
English
Change language to French French
Change language to Spanish Spanish
Change language to German German
Change language to Italian Italian
Change language to Portuguese Portuguese
Change language to Hebrew Hebrew
Change language to Hindi Hindi
Change language to Greek Greek
Change language to Chinese Chinese
Change language to Dutch Dutch
Change language to Norwegian Norwegian
Change Language
Close and do not switch language